Natalie Sacks insider trades

Open-market stock purchases and sales by Natalie Sacks, Director at Caribou Biosciences, Inc, from SEC Form 4 filings since Sep 12, 2016.

Recent trades

DateStockTradeValue
Feb 20, 2026CRBU Caribou Biosciences, IncBought (not open market)—

Companies traded

  • CRBU Caribou Biosciences, Inc: other filings, last Feb 20, 2026
  • ZYME Zymeworks Inc: other filings, last Dec 21, 2022
  • HARP Harpoon Therapeutics, Inc: 21 sales, last Jan 28, 2022
  • ADRO Aduro Biotech, Inc: 3 sales, last Sep 13, 2018

Get free alerts when Natalie Sacks files a new trade →